REG logo

REG

Regency Centers Corporation

$76.98
$0.00(0.00%)
64
Overall
100
Value
36
Tech
57
Quality
How is this score calculated?
Market Cap
$13.12B
Volume
1.99M
52W Range
$63.44 - $79.90
Target Price
$81.53

Latest News for REG

CICC Reaffirms Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
TipRanks Auto-Generated Intelligence Newsdesk3 days agoApr 03, 2026

In a report released yesterday, from CICC maintained a Buy rating on RemeGen Co. Ltd. Class H, with a price target of HK$133.71. In addition to CIC......

RemeGen Wins NMPA Nod to Start Clinical Trial of Bispecific ADC RC288
TipRanks HongKong Auto-Generated Newsdesk4 days agoApr 01, 2026

RemeGen Co. Ltd. Class H ( ($HK:9995) ) just unveiled an update. RemeGen Co., Ltd. announced that China’s National Medical Products Administration ......

Wells Fargo Sticks to Its Hold Rating for Regeneron (REGN)
TipRanks Auto-Generated Intelligence Newsdesk4 days agoApr 01, 2026

In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Regeneron, with a price target of $825.00. Bansal covers the ......

Regulus Resources Adopts Poison Pill as AntaKori Sulphide Project Advances
TipRanks Canadian Auto-Generated Newsdesk5 days agoApr 01, 2026

The latest announcement is out from Regulus Resources ( ($TSE:REG) ). Regulus Resources has adopted a shareholder rights plan aimed at preventing c......

Creactives Publishes Half-Year 2025 Consolidated Report for Investors
TipRanks Italy Auto-Generated Newsdesk5 days agoMar 31, 2026

Creactives Group S.p.A. ( ($IT:CREG) ) has issued an update. Creactives Group S.p.A., a Verona-based AI specialist for supply chain solutions deliv......

Wall Street Analysts Are Bullish on Top Healthcare Picks
Howard Kim6 days agoMar 31, 2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medios AG (MEDOF), Regeneron (REGN) and Siemens Heal......

RemeGen Boosts 2025 Revenue as Telitacicept Wins New Approvals and NRDL Access
TipRanks HongKong Auto-Generated Newsdesk9 days agoMar 27, 2026

RemeGen Co. Ltd. Class H ( ($HK:9995) ) has shared an update. RemeGen reported strong product sales revenue of about RMB2.31 billion for 2025, up 3......

Creactives boosts recurring revenues and partner sales as balance sheet strengthens
TipRanks Italy Auto-Generated Newsdesk11 days agoMar 25, 2026

An announcement from Creactives Group S.p.A. ( ($IT:CREG) ) is now available. Creactives Group reported a robust first half of fiscal 2025/26, with......

Creactives boosts recurring revenues and partner sales as balance sheet strengthens
TipRanks Italy Auto-Generated Newsdesk11 days agoMar 25, 2026

An announcement from Creactives Group S.p.A. ( ($IT:CREG) ) is now available. Creactives Group reported a robust first half of fiscal 2025/26, with......

RemeGen Wins Fourth NMPA Approval for Disitamab Vedotin in HER2-Low Breast Cancer
TipRanks HongKong Auto-Generated Newsdesk13 days agoMar 23, 2026

RemeGen Co. Ltd. Class H ( ($HK:9995) ) has provided an update. RemeGen has obtained approval from China’s National Medical Products Administration......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 21 articles.

ABCD
1SymbolPriceChangeVol
2REG$76.980%1.99M
3
4
5
6

Get Regency Centers Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.